Compare JOE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JOE | CLDX |
|---|---|---|
| Founded | 1936 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | 2002 | 1995 |
| Metric | JOE | CLDX |
|---|---|---|
| Price | $70.30 | $28.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $64.00 |
| AVG Volume (30 Days) | 204.9K | ★ 899.2K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 56.69 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $513,246,000.00 | $12,743,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.57 | $75.84 |
| P/E Ratio | $44.48 | ★ N/A |
| Revenue Growth | 27.44 | ★ 87.78 |
| 52 Week Low | $55.61 | $22.33 |
| 52 Week High | $75.66 | $45.14 |
| Indicator | JOE | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 43.45 |
| Support Level | $61.57 | $28.26 |
| Resistance Level | $72.29 | $31.83 |
| Average True Range (ATR) | 2.29 | 1.44 |
| MACD | 0.06 | 0.15 |
| Stochastic Oscillator | 37.86 | 26.35 |
The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.